Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC), defined as lack of estrogen and progesterone receptors in the absence of protein overexpression/gene amplification of human epidermal growth factor receptor 2, is still a clinical challenge despite progress in breast cancer care. (1)H magnetic resonance spectros...

Descripción completa

Detalles Bibliográficos
Autores principales: Iorio, Egidio, Caramujo, Maria José, Cecchetti, Serena, Spadaro, Francesca, Carpinelli, Giulia, Canese, Rossella, Podo, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043614/
https://www.ncbi.nlm.nih.gov/pubmed/27747192
http://dx.doi.org/10.3389/fonc.2016.00205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043614/
https://www.ncbi.nlm.nih.gov/pubmed/27747192
http://dx.doi.org/10.3389/fonc.2016.00205

Ejemplares similares